Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.

Florian Huemer (First author), Eckhard Klieser (Co-author), Daniel Neureiter (Co-author), Verena Schlintl, Gabriel Rinnerthaler (Co-author), Franck Pagès, Amos Kirilovsky, Carine El Sissy, Wolfgang Iglseder (Co-author), Franz Singhartinger (Co-author), Tarkan Jäger (Co-author), Adam Dinnewitzer (Co-author), Nadja Zaborsky (Co-author), Markus Steiner (Co-author), Richard Greil (Co-author), Lukas Weiss* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

11 Citations (Web of Science)
Original languageEnglish
JournalJournal of Clinical Medicine
Volume9
Issue number9
DOIs
Publication statusPublished - 2020

Keywords

  • LIGAND 1 EXPRESSION
  • CISPLATIN-INELIGIBLE PATIENTS
  • OPEN-LABEL
  • PREOPERATIVE CHEMORADIOTHERAPY
  • POSTOPERATIVE CHEMOTHERAPY
  • GERMAN CAO/ARO/AIO-04
  • SINGLE-ARM
  • PEMBROLIZUMAB
  • MULTICENTER
  • FLUOROURACIL

Cite this